Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research

McGill University

$66,000.00

The Role of ATP as an Activator of NcRTI-mediated Inhibition of Reverse Transcription in HIV-1

FY 2008-09

Summary
The reverse transcriptase (RT) enzyme of HIV-1 is responsible for the production of viral DNA. This enzyme is a major target in antiretroviral therapy due to its crucial role in viral replication. While current anti-HIV drugs are potent inhibitors, the development of viral resistance often leads to the loss of treatment efficacy. As such, the development of novel antiretroviral compounds remains an active area of research in the fight against AIDS. Nucleotide-competing RT Inhibitors (NcRTIs) represent a newly-discovered family of compounds which were discovered to be active against RT. These compounds appear to function through a biochemical mechanism distinct from all other RT inhibitors known to date. This research focuses on further characterizing this family of inhibitory compounds from a biochemical perspective. This study is conducive to the potential development of NcRTIs as compounds that may be used in the clinic to combat HIV infection.
Program
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
178074
Name
Ehteshami Akbari Maryam
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The Role of ATP as an Activator of NcRTI-mediated Inhibition of Reverse Transcription in HIV-1
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$66,000
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA: Biomedical/Clinical HIV/AIDS Research
Keyworddelim
Atp; Drug Resistance; Enzyme Kinetics; Fret Assays; Hiv Reverse Transcriptase; Mass Spectrometry; Mutations; Ncrti-1; Ncrtis; Site-Specific Footprinting
Abstract
The reverse transcriptase (RT) enzyme of HIV-1 is responsible for the production of viral DNA. This enzyme is a major target in antiretroviral therapy due to its crucial role in viral replication. While current anti-HIV drugs are potent inhibitors, the development of viral resistance often leads to the loss of treatment efficacy. As such, the development of novel antiretroviral compounds remains an active area of research in the fight against AIDS. Nucleotide-competing RT Inhibitors (NcRTIs) represent a newly-discovered family of compounds which were discovered to be active against RT. These compounds appear to function through a biochemical mechanism distinct from all other RT inhibitors known to date. This research focuses on further characterizing this family of inhibitory compounds from a biochemical perspective. This study is conducive to the potential development of NcRTIs as compounds that may be used in the clinic to combat HIV infection.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ehteshami Akbari, Maryam
Approvedterm
3 ans 0 mois
Cihrcontribution2
Science Policy 4~ $66,000~ $0~